GEC-ESTRO ACROP recommendations on calibration and traceability of LE-LDR photon-emitting brachytherapy sources at the hospital level-Reference-Cited by-同舟云学术

GEC-ESTRO ACROP recommendations on calibration and traceability of LE-LDR photon-emitting brachytherapy sources at the hospital level

Published:2019-06 Issue: Volume:135 Page:120-129
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Perez-Calatayud Jose^ORCID,Ballester Facundo^ORCID,Carlsson Tedgren Åsa,Rijnders Alex,Rivard Mark J.,Andrássy Michael,Niatsetski Yury,Schneider Thorsten,Siebert Frank-André

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference64 articles.

1. American Association of Physicists in Medicine. 1987. “Specification of Brachytherapy Source Strength.” AAPM Report No. 21, no. 21: 24.

2. Third-Party Brachytherapy Source Calibrations and Physicist Responsibilities: Report of the AAPM Low Energy Brachytherapy Source Calibration Working Group;Butler;Med Phys,2008

3. Quality Assurance Calibration of 125I Rapid Strand in a Sterile Environment;Butler;Int J Radiat Oncol Biol Phys,1998

4. Third party brachytherapy seed calibrations and physicist responsibilities;Butler;Med Phys,2006

5. Assaying Multiple 125I Seeds with the Well-Ionization Chamber SourceCheck4π 33005 and a New Insert;Candela-Juan;J Contemporary Brachyther,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An efficient component of the redundancy calibration program to ensure equipment stability by assaying HDR Ir‐192 sources at the time of replacement;Journal of Applied Clinical Medical Physics;2024-09-05

2. GEC-ESTRO survey of 106Ru eye applicator practice for ocular melanoma – Physicist survey;Radiotherapy and Oncology;2024-04

3. Current status and issues with the dosimetric assay of iodine-125 seed sources at medical facilities in Japan: a questionnaire-based survey;Journal of Radiation Research;2023-09-11

4. Risk and Quality in Brachytherapy From a Technical Perspective;Clinical Oncology;2023-08

5. Introducing the ESTRO Guidelines Committee, the driving force for the new generation of ESTRO guidelines;Radiotherapy and Oncology;2023-08